H. Yoon

Characteristics of necrotizing fasciitis in three university hospitals in Korea

Tae Hyong Kim, Sang-Wook Park, K. Cheon, 2006 .

LBA-1 RATIONALE-306: Randomized, global, placebo-controlled, double-blind phase 3 study of tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma (ESCC)

E. Raymond, L. Wyrwicz, J. Shi, 2022, Annals of Oncology.

The change of serum level of total antioxidant status and cytokine, andin-stent restenosis after supplementation of antioxidant

Jihun Ahn, D. Bang, M. Hyon, 2006 .